UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047331
Receipt number R000053981
Scientific Title Shared decision making on dialysis modality selection in Japan: a cross-sectional study
Date of disclosure of the study information 2022/03/30
Last modified on 2024/08/21 10:38:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Shared decision making on dialysis modality selection in Japan: a cross-sectional study

Acronym

Shared decision making on dialysis modality selection in Japan: a cross-sectional study

Scientific Title

Shared decision making on dialysis modality selection in Japan: a cross-sectional study

Scientific Title:Acronym

Shared decision making on dialysis modality selection in Japan: a cross-sectional study

Region

Japan


Condition

Condition

Chronic Kidney Disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of the present study is to determine the degree of shared decision making and decision conflict among dialysis patients and physician in Japan.

Basic objectives2

Others

Basic objectives -Others

To improve the quality of care of chronic kidney disease

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Shared decision making questionnaire, Decision Conflict Scale

Key secondary outcomes

1)Relationship between above mentioned score
2) Relationship between Shared decision making score for patient and physician


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Adult over age of 18, who understand written Japanese.
Patients who newly started dialysis therapy, or Nephrologist who supported patients' decision making.

Key exclusion criteria

Those who do not meet inclusion criteria

Target sample size

720


Research contact person

Name of lead principal investigator

1st name Yasuhiro
Middle name
Last name Komatsu

Organization

Gunma University Graduate School of Medicine

Division name

Department of Healthcare Quality and Safety

Zip code

371-8511

Address

3-39-22 Showamachi, Maebashi, Gunma Prefecture

TEL

027-220-8767

Email

komayasu@gunma-u.ac.jp


Public contact

Name of contact person

1st name Yasuhiro
Middle name
Last name Komatsu

Organization

Gunma University Graduate School of Medicine

Division name

Department of Healthcare Quality and Safety

Zip code

371-8511

Address

3-39-22 Showamachi, Maebashi, Gunma Prefecture

TEL

027-220-8767

Homepage URL


Email

komayasu@gunma-u.ac.jp


Sponsor or person

Institute

Gunma University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Baxter Limited

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gunma University Ethical Review Board for Medical Research Involving Human Subjects

Address

3-39-22 Showamachi, Maebashi, Gunma Prefecture

Tel

027-220-8740

Email

hitotaisho-ciru@ml.gunma-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 03 Month 30 Day

Date of IRB

2022 Year 04 Month 15 Day

Anticipated trial start date

2022 Year 05 Month 16 Day

Last follow-up date

2022 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observational study using survey questionnaire


Management information

Registered date

2022 Year 03 Month 30 Day

Last modified on

2024 Year 08 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053981